Funding for this research was provided by:
Abbott Laboratories
Article History
Accepted: 30 March 2022
First Online: 19 April 2022
Change Date: 28 July 2022
Change Type: Update
Change Details: The original version of this paper was updated to present the correct author names.
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The salary of KCCM is funded by a fellowship from Abbott. CEA has chaired the Steering Committee of the MEMS-HF study and is co-chairing the steering committee of the PASSPORT-HF study. She further declares grant support, personal fees and/or non-financial support from Abbott, Astra-Zeneca, Boehringer Ingelheim, Medtronic, Novartis, ResMed, Thermo Fisher and Vifor, all outside of the submitted work, and acknowledges non-financial support from the University Hospital Würzburg, non-financial support from Comprehensive Heart Failure Centre Würzburg and grant support from the German Ministry for Education and Research (BMBF). CEA is Editor-in-Chief of Current Heart Failure Reports. MRC chairs the steering committee of the COAST study and was a member of the MANAGE-HF, DOT-HF, HOME-HF, SENSE-HF and REM-HF steering committees. MRC has provided consultancy advice to AstraZeneca, Novartis, Bayer, Roche diagnostics, Sevier, Fire1foundry, Abbott, Medtronic and Boston Scientific. His hospital receives research grants for a fellowship—currently held by KCCM.